Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio-Techne Corp (NASDAQ:TECH)

92.00
BATS BZX Real-Time Price
As of 3:53pm ET
 -1.00 / -1.08%
Today’s Change
86.01
Today|||52-Week Range
114.56
-0.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5B

Company Description

Bio-Techne Corp. engages in the development, manufacture, and sale of biotechnology products and clinical diagnostic controls. It operates in the Biotechnology and Clinical Controls segment. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products. The Clinical Controls segment involves in the development and manufacture of controls and calibrators for the global clinical market. The company was founded on July 17, 1981 and is headquartered in Minneapolis, MN.

Contact Information

Bio-Techne Corp.
614 McKinley Place NE
Minneapolis Minnesota 55413-2610
P:(612) 379-2956
Investor Relations:

Employees

Shareholders

Mutual fund holders58.49%
Other institutional43.33%
Individual stakeholders0.41%

Top Executives

Charles R. KummethPresident, Chief Executive Officer & Director
James T. HippelCFO, VP-Finance & Principal Accounting Officer
J. Fernando BazanChief Technology Officer
Brenda S. FurlowSenior Vice President & General Counsel
Norman David EansorSenior Vice President